<DOC>
	<DOCNO>NCT00597727</DOCNO>
	<brief_summary>The specific aim study determine peanut allergen-specific SLIT cause clinical desensitization tolerance develop peanut-allergic young child .</brief_summary>
	<brief_title>A Study Sublingual Immunotherapy Peanut-allergic Children</brief_title>
	<detailed_description>In spite increase recognition understand food allergy , food-induced anaphylaxis remain single common cause anaphylaxis see hospital emergency department , account one third anaphylaxis case see . It estimate 30,000 food-induced anaphylactic event see U.S. emergency department year 200 fatal case occur U.S. year . Either peanut tree nut cause 80 % reaction . No treatment available avoidance approve intervention . The goal study investigate peanut sublingual immunotherapy ( SLIT ) treatment child peanut allergy . This study design evaluate efficacy safety peanut SLIT compare placebo 12 month . Mechanistic study complete concurrently understand change allergic immune response relate peanut SLIT . The remainder study design evaluate efficacy peanut SLIT induce last tolerance discontinuation peanut SLIT .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>Peanut IgE &gt; 7kU/L ( &gt; 2kU/L child age 2 year ) AND History significant clinical symptom within 60 minute ingestion peanut . History severe lifethreatening anaphylaxis peanut , OR Medical history would prevent DBPCFC peanut , OR Subjects wheat oat allergy ( use placebo ) , OR Unable cooperate challenge procedure , OR Unable reach telephone followup</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Peanut Allergy</keyword>
	<keyword>Sublingual immunotherapy</keyword>
</DOC>